New pneumonia vaccine for infants enters final testing phase

NCT ID NCT07017777

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: CanSino Biologics Inc. Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 14, 2026 · Updated 9 times

Summary

This study tests a new vaccine (PCV13i) to protect healthy infants from pneumococcal infections, which can cause pneumonia and meningitis. About 600 babies in Thailand will receive either the new vaccine or an existing one. Researchers will check if the new vaccine triggers a strong immune response and is safe, with follow-up after each dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Faculty of Medicine Siriraj Hospital, Mahidol University
RECRUITING

Bangkok, Thailand

Contact
King Chulalongkorn Memorial Hospital
RECRUITING

Bangkok, Thailand

Contact
Phramongkutklao Hospital
RECRUITING

Bangkok, Thailand

Contact

Conditions

Explore the condition pages connected to this study.

BACTERIAL INFECTIONS BACTERIAL INFECTIONS PNEUMOCOCCAL INFECTIONS STREPTOCOCCAL INFECTIONS